Concepedia

Ziad Bakouny

ZB

Statistics

Publications

72

Citations

7.8K

H-Index

35

Active since

2016

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

The University of Texas MD Anderson Cancer Center

Saint Joseph University

Ziad Bakouny is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and renal cell carcinoma.

ORCID

Publications per year

2016–2025

72

Publications

72

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +8

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

David A. Braun, Yue Hou, Ziad Bakouny et al. · Nature Medicine · 2020 · 1K citations · Full text

, , +16

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Kevin Bi, Meng Xiao He, Ziad Bakouny et al. · Cancer Cell · 2021 · 628 citations · Full text

, , +17

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

David A. Braun, Kelly Street, Kelly P. Burke et al. · Cancer Cell · 2021 · 517 citations · Full text

, , +15

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper et al. · Annals of Oncology · 2021 · 326 citations · Full text

, , +10

1–5 of 72